Plain-English translation of NCT06003101 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether using your own cells—specifically platelet-rich plasma, platelet-poor plasma, and bone marrow aspirate concentrate—applied during hip arthroscopy surgery can help you recover better after labral tear repair. The labrum is the cartilage ring around your hip socket that helps keep your hip stable. By adding these healing cells during surgery, researchers hope to improve pain relief and hip function long-term.
Hip labral tears are common and can lead to early arthritis if not treated well. While surgeons now focus on repairing rather than removing the labrum, the challenge is helping the repair heal strongly and preventing future problems. This treatment aims to boost your body's natural healing ability using your own cells.
You likely qualify if…
You likely don't qualify if…
You will undergo hip arthroscopy surgery at Massachusetts General Hospital. Before surgery, you'll be randomly assigned to either receive the standard repair procedure alone, or the same procedure with an application of healing cells harvested from your own blood and bone marrow. After surgery, you'll complete follow-up visits and answer questions about your hip pain, function, and quality of life to help researchers measure how well you're healing.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United States